Labcorp’s third quarter results met Wall Street’s revenue expectations, but the market responded negatively, reflecting investor concerns about profitability and future growth levers. Management ...

According to Nova One Advisor, the global exosome research market size is calculated at USD 225.72 million in 2025 and is ...

Here is everything we know about Elon Musk’s 14 children, who he shares with four partners: Justine Wilson, Grimes, Shivon ...

MIAMI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and nine months ended September 30, 2025. Highlights ...

Morgan Stanley analyst Sarita Kapila raised the firm’s price target on Roche (RHHBY) to CHF 255 from CHF 245 and keeps an Underweight rating on ...

BLS revenue reached $799 million, up 8.3%, and adjusted operating income grew to $132 million. The quarter ended with an $8.6 billion backlog, and the BLS book-to-bill was 0.89 for the quarter and ...

Updates Full-Year Guidance Financial results from Operations for third quarter 2025 versus third quarter 2024: Revenue: $3.56 billion versus $3.28 billion ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced results for the third quarter ended September 30, 2025 and updated full-year guidance.

Raises FY25 free cash flow view to $1.17B-$1.29B from $1.13B-$1.28B. The company said, “Labcorp (LH) is updating 2025 full year guidance to reflect its third quarter performance and full year outlook.

Labcorp, one of the country’s largest providers of diagnostic medical testing services, announced today that it will offer ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys pTau181 test, the only blood test cleared by the U.S. Food and Drug ...

Scientists at CSIRO, Australia's national science agency, have identified simpler and less invasive methods to improve ...